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Cisplatin (cDDP) is one of the most widely used chemotherapeutic
agents, but its effectiveness is limited by both intrinsic and acquired
resistance. Acquired resistance appears to be multifactorial in that
many different mechanisms participate in the defence of the cell
(Los and Muggia, 1994). The mechanisms thus far identified
include impaired uptake of the drug, increased efflux, intracellular
detoxification by, e.g. glutathione, tolerance to the cDDP-DNA
adducts and increased repair of DNA damage (Los and Muggia,
1994). The details of the biochemical steps involved have not been
fully elucidated, and little information is available on how these
disparate mechanisms are coordinated with each other. However,
development of acquired resistance is likely to be accompanied by
an altered pattern of gene expression in the cell. Changes in cDDP
sensitivity have been reported in cells molecularly engineered to
overexpress a variety of genes including myc, H-ras, fos, jun
(Chatterjee et al, 1995), ErbB-2 (Alaoui-Jamali et al, 1997), HER-2
(Marth et al, 1997), metallothionein II (Yamada-Okabe et al, 1995),
p53 (Chatterjee et al, 1995), bcl-2 (Miyake et al, 1998), and
hMSH2 (Fink et al, 1996). However, whether any of these play a
role in naturally-occurring acquired resistance is uncertain.
The goal of this study was to identify genes whose differential
expression in cisplatin-resistant cells could be used to identify the
resistant phenotype. We chose the approach of comparing a
parental cell line with its isogenic subline that had been selected for
acquired cDDP resistance by repeated in vitro exposure to the drug
(Nakata et al, 1994). A variety of methods are now available for
comparing patterns of gene expression, including differential
hybridization screening (Tedder et al, 1988), subtractive library
construction (Hedrick et al, 1984), representational difference
analysis (RDA) (Hubank and Schatz, 1994), cDNA array
hybridization (Schummer et al, 1997), serial analysis of gene
expression (SAGE) (Velculescu et al, 1995) and suppression
subtractive hybridization (SSH) (Diatchenko et al, 1996). The latter
technique was selected for this study as it has the advantage of
normalizing for mRNA abundance so that both low and high copy
number mRNAs can be identified under conditions where they are
differentially expressed. This approach has been recently reported
to be productive in identifying differentially expressed genes in
other model systems (Kuang et al, 1998; Yang et al, 1999).
In the present investigation, we used SSH to construct libraries
representing mRNAs differentially expressed in the parental
cDDP-sensitive human squamous cell carcinoma cell line
uMSCC10b and a 5.9-fold cDDP-resistant subline. Two cDNA
libraries were prepared, one containing cDNA fragments corre-
sponding to mRNAs whose levels were increased in resistant cells
(UP library), and the other containing cDNA fragments corre-
sponding to mRNAs whose abundance was reduced in the
resistant cells (DOWN library). Filter microarray hybridization
was then used to document differential expression.
MATERIAL AND METHODS
Cells
The experiments were performed with the UMSCC10b human
head and neck carcinoma cell line (Krause et al, 1981) and a variant
selected in vitro with cDDP for acquired resistance (Nakata et al,
1994). This resistant variant, UMSCC10b/Pt-S15, was selected by
a total of 15 repeated exposures of the parental cells to increasing
concentrations of cDDP and was 5.9-fold resistant to cDDP as
determined by clonogenic assay (Nakata et al, 1994). All cells were
cultured in RPMI 1640 (Irvine Scientific, Santa Ana CA, USA)
supplemented with 2 mM l-glutamine, 100 units ml–1 of penicillin
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G, 100 mg ml–1 of streptomycin sulphate and 10% fetal bovine
serum (Gibco BRL, Grand Island NY, USA).
mRNA extraction
The mRNA used for library construction was isolated from 80%
confluent cells by acid guanidium pheno–chloroform extraction
(Chomczymski and Sacchi, 1987) followed by isolation of poly(A)+
mRNA using the Oligotex mRNA Midi Kit (Qiagen Inc, Chatsworth
CA, USA). The mRNA used to make cDNA-probes directly from
tumour cells was isolated by using the mRNA Direct Kit (Qiagen).
Suppression subtractive hybridization (SSH)
SSH was performed using the ClonTech PCR-select cDNA
Subtraction kit (Clontech Laboratories Inc, Palo Alto CA, USA)
according to the manufacturer’s instructions. Forward subtractions
used cDNA fragments generated from the mRNA of the
UMSCC10b/Pt-S15 subline as tester, and fragments generated
from the parental UMSCC10b cells as driver. Reverse subtractions
used UMSCC10b/Pt-S15 fragments as the driver. Single-stranded
cDNA was made using 2 µ g of mRNA from each cell line with
random primers and MMLV reverse transcriptase. Double-
stranded cDNA was synthesized with an enzyme-cocktail
containing DNA polymerase I, RNase H, and E. coli DNA ligase,
followed by T4 DNA polymerase. A RsaI digestion was then
performed to obtain shorter, blunt-ended molecules. For each
subtraction, two tester populations were created by ligating two
different adaptors, named 1R and 2R, onto the tester cDNA
fragments. No adaptors were ligated to the driver cDNA. In a first
hybridization, excess driver cDNA was mixed with tester cDNA
containing adaptors 1R and 2R, respectively, in two different
reactions. The tester:driver ratio was 1:100. The reactions were
denatured and allowed to anneal. In a second step, these two tester-
driver mixtures were hybridized together. This was followed by a
primary PCR with 30 cycles and secondary PCR for 12 cycles with
primers specific for the two adaptors. After the SSH procedure,
theoretically only cDNA fragments that were present in greater
abundance in the tester than in the driver population were
equipped with both adaptors 1R and 2R. Therefore, only these
fragments were exponentially amplified during the final PCR step,
leading to an enrichment of the differentially expressed genes.
TA cloning
The PCR products derived from the final SSH step were ligated
into the pCR*2.1 vector by using the TA Cloning Kit (Invitrogen
Co, Carlsbad CA, USA) to produce libraries of SSH-derived frag-
ments. The ligation reaction products were then transformed into
competent INVaF′ bacteria which were cultured on LB agar plates
containing ampicillin and X-galactose for blue–white screening.
White colonies were picked, incubated in Terrific Broth, a cocktail
of bacto-tryptone (Fisher Biotech, Fair Lain NY, USA), bacto-
yeast extract (Difco, Detroit MI, USA), glycerol (Fisher Biotech),
KH2PO4 (Sigma, St Louis MO, USA), K2HPO4 (Sigma) and
ampicillin (Fisher Biotech) and than frozen in glycerol at –80° C.
Isolation of cDNA inserts
PCR using AmpliTaq polymerase (Perkin Elmer, Norwalk CT,
USA) and nested primers directed against the inner 21 bases of
adaptors 1R and 2R was performed to identify which bacterial
clones contained cDNA inserts. A Perkin-Elmer Cetus DNA
Thermal Cycler was programmed as follows: 94° C for 10 min to
lyse the bacteria; 30 cycles of denaturation at 94° C for 30 s,
annealing at 68° C for 1 min, and extension at 72° C for 1 min 30 s;
final extension at 72° C for 7 min. The samples were then
electrophoresed on a 1.2% agarose gel and the clones yielding a
single PCR product were selected for further investigation.
Preparation of membrane arrays
The PCR-products containing a cDNA fragment were denatured
with 0.6 M NaOH and 1 µ l of each fragment was dotted onto
Magna Graph nylon membranes (Micron Separation Inc,
Westborough MA, USA). Each membrane consisted of a
maximum of 108 dots. Serial dilutions of the whole population of
cDNA fragments recovered from forward or reverse SSH steps
were also included in the arrays as internal controls. The
membranes were neutralized with Tris-HCl and crosslinked with
120 mJ cm–2 in a FB-UVXL-1000 UV Crosslinker (Fischer
Scientific, Pittsburgh PA, USA) and stored in plastic wrap until
hybridization.
Preparation of cDNA probes
Three types of cDNA probes were used in this study. The first was
PCR-amplified cDNA fragments recovered from either the
forward or reverse SSH step and which putatively contained only
cDNA fragment corresponding to differentially expressed
mRNAs. These are referred to as forward and reversed subtracted
probes. The PCR products were purified using the Advantage
PCR-Pure Kit (Clontech), and the adaptors were then removed by
digestion with the restriction enzymes Rsa I, Sma I and Eag I.
These probes were used for the primary differential screening.
The second type of probe consisted of cDNA prepared from
mRNA isolated from the two cell lines which was then PCR
amplified and radiolabelled following ligation of adaptors 1R and
2R (unsubtracted PCR-amplified cDNA probes). Purification and
removal of adaptors was accomplished in the same manner as for
the subtracted probes. These probes were used to obtain an esti-
mate of the degree of differential expression in cDDP-resistant vs
sensitive cells.
The third type of probe consisted of cDNA from the parental
UMSCC10b cell line, prepared by reverse transcription of total
cellular mRNA, using the reagents of the PCR-select cDNA
Subtraction Kit, that was then fragmented by digestion with Rsa I
(non-amplified cDNA probes). This probe was used to study the
background abundance of the gene fragments.
All probes were labelled with 32P by utilizing the Multiprime
Labeling Kit (Amersham Life Science, Arlington Heights IL,
USA), with 20 ng of cDNA per probe, followed by purification
with Chroma Spin-100 (Clontech) columns. The specific activity
of the purified probes ranged from 5 × 107 to 8 × 108 cpm µ g–1
DNA.
Array hybridization
The membrane arrays were incubated for 1 h at 68° C with 10 ml of
prehybridization solution (0.2% SDS, 10 mM EDTA, 5 
Denhardt’s, 5  SSC, 2.5 mg salmon sperm DNA, 50 ml of
blocking solution (Clonetech)) in glass hybridization tubes in aHybridization Incubator Model 400 (Robbins Scientific Co,
Sunnyvale CA, USA). The radioactive probes were added and the
tubes were incubated for another 16 h at 68° C. The final probe
concentration in the hybridization tubes was approximately 
5 ng ml–1. The membranes were rinsed in 2  SSC, 0.2% SDS at
68° C for 4 × 20 min. Hybridizations with subtracted SSH-derived
and unsubtracted PCR-amplified probes were performed in tripli-
cate and hybridizations with non-amplified cDNA probes were
performed in duplicate.
Array imaging
Analysis of the extent of hybridization was accomplished with an
imaging system from Bio-Rad Laboratories, Hercules CA, USA.
Membranes were exposed to a Molecular Imaging Screen-BI in a
GS-250 Sample Loading Dock for a time-period ranging from
3–12 h. The exposure time was determined empirically based on
the radioactive intensity of the membranes as estimated by a
Geiger–Müller counter. The exposed screens were then transferred
to a Molecular Imager GS-525 and the data were analysed with the
PC-based Molecular Analyst Software. A 96-circle grid with local
background subtraction was applied. The three-dimensional
volume analysis function was used, which gives a measure of the
total signal density, including size of the dot as well as the intensity
of each individual pixel. The presented values thus represent the
total radioactivity per dot and are expressed as counts × mm2. Due
to the local background correction, some array elements yielded
very low or negative values. To permit calculation of relative
hybridization intensities, elements with signals of < 10 counts 
× mm2 were assigned a value of 10 which corresponded to the
visual limit of detection.
Sequencing and identification of identified fragments
Plasmids containing cDNA fragments that were differentially
expressed were sequenced using either primers homologous to the
M13 reversed priming site of the plasmid, or nested primers
targeted to adaptors 1R or 2R. The sequencing was performed with
a 373 XL Automated DNA Sequencer (Perkin-Elmer/Applied
Biosystems) at the UCSD Core Facility. The sequences were
submitted for Sequence Similarity Search (BLAST search) at
the GenBank of the National Center for Biotechnology Informa-
tion (Internet address: http://www.ncbi.nlm.nih.gov). Fragments
showing high homology (P < 0.05) with previously described
sequences were considered to represent known genes. Fragments
with high homology with more than one gene were identified on the
basis of highest homology of human origin. The mRNAs for which
no homology (P > 0.05) was found were considered unknown.
RESULTS
Library construction and differential screening
SSH was used to create a population of cDNA fragments corre-
sponding to mRNAs whose levels were either increased (the UP
library) or decreased (the DOWN library) in the cDDP-resistant
UMSCC10b/Pt-S15 subline relative to the parental UMSCC10b
cells. Figure 1 presents a flow diagram of the yield from each step
of the isolation procedure. The population of subtracted cDNA
fragments was ligated into a plasmid vector, and the resulting
libraries were transformed into bacteria. A total of 200 vector-
containing bacterial colonies were picked for each library and
assayed for the presence of a cDNA insert by PCR using primers
specific for the adaptors ligated on either end of the insert. A single
PCR product was found in 80% of the bacterial colonies from the
UP library and 59% of the colonies from the DOWN library.
The PCR products generated from the inserts were arrayed on
membranes, and the arrays were hybridized with forward and
reversed subtracted probes, consisting of the population of cDNA
fragments obtained from the SSH step from which the adaptors
had been removed, to identify those elements of the array that
corresponded to truly differentially expressed mRNAs. Array
elements demonstrating > 5-fold differences in abundance in the
UP and DOWN subtracted libraries in at least one of three repeat
hybridizations were selected for further investigation. Based on
this criterion, there was a clear difference in the frequency of
differentially expressed cDNAs in the two libraries. Among the
inserts isolated from the UP library, 47 of 159 (30%) were > 5-fold
differentially represented, whereas only 16 of 118 inserts (13%)
from the DOWN library met this criterion.
Differential gene expression in cDDP resistance 1049
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Figure 1 Flow diagram showing the number of cDNA fragments processed
for the UP and DOWN librariesIn order to assess the variation between array hybridizations, the
number of cDNAs meeting the 5-fold criteria was determined
from each of three separate hybridizations to different copies of
the same array. Tables 1 and 2 present the degree of differential
expression detected by each independent hybridization. Among
the 47 fragments that demonstrated a > 5-fold difference in 
abundance on at least one hybridization, 37 (79%) demonstrated a
difference of this magnitude in at least two of the three experi-
ments. In other words, if the 5-fold cut-off was exceeded in the
first experiment for a given cDNA, there was a 79% chance that
the same fragment would be scored as meeting this criterion in a
least one of two additional hybridizations. Of the fragments that
demonstrated a > 5-fold difference in only one of the three
hybridizations, 90% still showed a difference of more than 2-fold
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Table 1 UP library: identity and differential screening, ratios of hybridization signals with forward:reversed subtracted probes, in fold-difference categories,
obtained from three separate experiments
Clone Fragment GenBank Level of differential Function
number identity identity expression
Exp. 1 Exp. 2 Exp. 3
21 NADH dehydrogenase HUMMTCG 3 ND 2
51 Cytochrome oxidase I HUMMTCG 3 3 3
50 Cytochrome oxidase I HUMMTCG 3 3 3 Oxidative metabolism
48 Cytochrome oxidase I HUMMTCG 3 3 3
47 Cytochrome oxidase I HUMMTCG 3 3 3
49 Ribosomal 28S HUMRGM 3 3 3
42 Ribosomal 28S HUMRGM 3 ND 3
34 Ribosomal 28S HUMRGM 3 3 3
32 Ribosomal 28S HUMRGM 3 3 3 Protein
30 Ribosomal 28S HUMRGM 3 1 2 synthesis
27 Ribosomal 28S HUMRGM 2 3 2
6 Ribosomal 28S HUMRGM 2 3 1
11 Ribosomal S15a HSRPS15A 2 2 1
28 EF1 α HSEF1AC 2 1 3 Protein synthesis, transformation,
25 EF1 α HSEF1AC 2 1 1 cytoskeletal organization,
8 EF1 α HSEF1AC 1 1 1 oncogene association
46 G6PDH HSG6PDR 2 2 3 Metabolism, transformation
resistance to radio-or chemotherapy
19 GAPDH HUMGAPDH 2 1 2
16 GAPDH HUMGAPDH 2 2 1 Metabolism, transformation
14 GAPDH HUMGAPDH 3 ND 2
43 α -enolase HUMENOA 3 3 3
31 α -enolase HUMENOA 2 3 3 Plasminogen receptor, resistance (rad or chemo)
18 α -enolase HUMENOA 2 3 2
38 Tyrosine kinase HSTRKE 2 3 2 Unknown
23 PGK HSPKG1 3 3 3 Metabolism
3 Prohibitin S85655 1 3 1 Immortalization, transformation
26 Integrin α 6 HSINTA6 3 1 2 Adhesion, resistance (rad or chemo)
40 Desmoplakin HUMDPI 1 3 2 Adhesion
20 Ca channel α 1 HUMCACNLS 1 ND 1 Ion transport
22 ARPF HUMAPRF 1 3 1 Response to cytokines
9 Interferon γ gene HSU10360 1 1 2 Response to Interferon, protease
29 HSP70 HSC70P 2 1 2 Stress response, resistance (rad or chemo)
44 Stathmin HSRNSTATH 1 2 3 Oncogene association, proliferation, microtubular
37 Stathmin HSRNSTATH 2 3 3 Oncogene association, proliferation, microtubular
1 GTP binding protein HSGTPBPA 3 ND 3 Metabolism
4 GDP diss inh HUMHRGAA 1 2 2 Metabolism
15 TATA-binding protein HSU13991 1 2 3 Association with oestrogen receptor
17 β -actin HSAC07 1 2 1
39 p21-Arc AF006086 2 ND 3 Cytoskeletal organization
35 Keratin 6 HUMKRT6A09 2 3 3
24 β -tubulin HSTUB2 2 ND 2 Microtubular function
13 β -tubulin HSTUB3 1 ND 1 Microtubular function
41 β -amyloid A4 HSAPA4R 3 ND 3 Unknown
45 Unknown 3 ND 3
36 Unknown 2 2 3
33 Unknown 1 3 1
12 Unknown 1 2 2
10 Unknown 1 2 1
7 Unknown 2 3 3
5 Unknown 3 2 3
2 Unknown 1 2 1
3 = > 20 fold, 2 = 5–20 fold, 1 = < 5 fold, ND = not determined; the level of differential expression refers to the ratio of hybridization signals obtained with forward
and reversed subtracted cDNA probes, performed in three separate experiments; EF1α = elongation factor 1α ; G6PDH = glucose-6-phosphatase
dehydrogenase; GAPDH = glyceraldehyde-3-phosphatase dehydrogenase; PGK = phospho glycerate kinase; APRF = acute phase response factor; 
HSP70 = heat shock protein 70
}
}
}
}
}
}in at least one of the two additional hybridizations. Thus, among
the fragments identified as showing > 5-fold differential
abundance on the first array hybridization, 46 of 47 (98%)
demonstrated at least 2-fold differential expression on repeat
hybridization. For these reasons, we concluded that the 5-fold cut-
off applied to a single array hybridization was adequate for
screening purposes.
Identification of cDNA fragments
The cDNA fragments corresponding to the 47 mRNAs in the UP
library and 16 mRNAs in the DOWN library that demonstrated 
> 5-fold differential expression in at least one hybridization were
sequenced along with four additional fragments that also were
included in the UP library, two of which had ratios of > 4.5 and
two that showed ratios between 2 and 3 on all three independent
hybridizations. Tables 1 and 2 show that 58 (87%) of these were
identifiable as segments of cDNAs contained in GenBank, and
nine (13%) were unknown. Some genes were identified more than
once. mRNA encoding cytochrome oxidase I, ribosomal protein
28S, elongation factor-1α (EF-1α ), glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), α -enolase,  β -tubulin, and stathmin
were identified multiple times in the UP library (Table 1), and
ribosomal proteins L10 and S6 were found more than once in the
DOWN library (Table 2).
Estimation of library size
Assuming that the original cDNA library represented all mRNAs
expressed in the cell, since the SSH technique normalizes the
abundance of the mRNAs, an estimate of the number of mRNAs
that are differentially expressed between the parental UMSCC10b
and UMSCC10b/Pt-S15 cells can be made from the number of
duplicates recovered. Of the 51 fragments in the UP library, the
gene to which these corresponded could be identified in 43. Of
these 43, 19 were recovered once, two were recovered twice, three
three times, one four times, and one seven times. The method of
Chao (1987) yielded an estimate of 116 cDNAs whose cognate
gene could be identified in GenBank in the UP library (95% CI
47–409). To accommodate the fact that the cognate gene could not
be identified for some of the differentially represented cDNAs, this
estimate should be increased by a factor of 51/43, resulting in an
adjusted estimate of 138 genes. Of the 16 fragments in the DOWN
library, 15 were identified as belonging to sequences in Genbank.
Eleven were recovered only once and two were recovered twice.
This yields an estimated library size of 43 (95% CI 19–158). The
estimate adjusted for cDNAs whose cognate gene could not be
identified in GenBank is 46. These calculations suggest that
approximately 25% of the mRNAs that are actually differentially
expressed in the UMSCC10b and UMSCC10/Pt-S15 cells are
represented in the subtracted libraries. However, the estimates of
the library size are based on relatively small numbers of cDNAs
isolated more than once and values as low as 10% or as high as
50% are consistent with these data.
Magnitude of differential expression determined by
reverse Northern blot analysis
The magnitude of the difference in abundance between the cDDP-
sensitive and -resistant cells in the 51 cDNAs included in the UP
and the 16 cDNAs of the DOWN libraries was examined further
by reverse Northern blotting. cDNA was prepared from the mRNA
of the sensitive or resistant cells, adaptors were ligated, and the
cDNA population PCR amplified, radiolabelled and used to probe
the filter arrays. These hybridizations were repeated three times
and the mean level of differential expression for each element in
the array was calculated as the ratio between resistant and sensitive
cells (Figure 2). Among the 51 cDNAs included in the UP library,
40 (78%) corresponded to mRNAs that demonstrated at least a 1.7-
fold difference in level, 18 (35%) at least a 5-fold difference, 12
(20%) a > 10-fold difference, and eight (16%) a > 20-fold differ-
ence. Particularly high ratios were observed for mRNAs encoding
cytochrome oxidase I, ribosomal protein 28S, glucose-6-phos-
phate dehydrogenase G6PD), stathmin and unknown clone #45.
Among the 16 cDNAs in the DOWN library, seven (44%) demon-
strated at least a 1.7-fold difference in expression and three (19%)
Differential gene expression in cDDP resistance 1051
British Journal of Cancer (2000) 83(8), 1047–1054 © 2000 Cancer Research Campaign
Table 2 DOWN library: identity and differential screening, ratios of hybridization signals with reversed: forward subtracted probes, in fold-
difference categories obtained from three separate experiments
Clone Fragment identity GenBank Level of differential Function
number identity expression
Exp. 1 Exp. 2 Exp. 3
–8 Ribosomal L9 HSU09953 2 1 1
–1 Ribosomal L10 HUMRP10A 2 2 1
–10 Ribosomal L10 HUMRP10A 1 2 1
–13 Ribosomal L12 HUML12A 1 3 3
–2 Ribosomal L27 HSU14968 3 3 3 Protein synthesis
–3 Ribosomal L41 AF026844 3 3 3
–4 Ribosomal S3a HUMRPSA3A 1 2 1
–14 Ribosomal S6 HUMRPS6A 2 2 1
–11 Ribosomal S6 HUMRPS6A 1 2 1
–7 Acidic ribosomal phosphoprotein HUMPPARP0 1 1 2
–15 ADP ribose polymerase HUMPPOL 2 ND 1
–9 Aldo-ketoreductase HUMALRM 2 ND 1 Metabolism
–5 Triosephosphate isomerase HUMTPI 1 2 1
–6 γ -actin HSACTCGR 2 1 1 Cytoskeletal organization
–16 Proliferation-associated gene HSPAG 2 2 1 Proliferation
–12 Unknown 2 2 2 Unknown
3 = > 20-fold; 2 = 5–20-fold; 1 = < 5-fold; ND = not determined
}
}
}at least a 5-fold difference. None had a > 10-fold difference. Six
(38%) of the fragments had a ratio of < 1.0, suggestive of a down-
regulation in the resistant cell line.
Abundance of differentially expressed mRNAs
The distribution of the absolute abundance in the parental
UMSCC10b cells of each differentially expressed mRNA provides
a test of the ability of the SSH technique to recover low vs high
abundance transcripts. The absolute abundance of the mRNA
corresponding to each cDNA fragment meeting the criteria for
differential expression was estimated from analysis of the
hybridization signal obtained by probing the arrays with non-
amplified cDNA prepared by reverse transcription from total
mRNA harvested from the UMSCC10b cells. The mRNAs were
arbitrarily categorized as being of low (< 10 counts × mm2, i.e.
below the visual detection limit), medium (10–100 counts × mm2),
and high (> 100 counts × mm2) abundance. Results from array
elements corresponding to mRNAs of the same identity were aver-
aged together. In the UP library, 66% of the mRNAs were of low
abundance, 25% of medium and 9% of high abundance. In the
DOWN library 7%, 64%, and 29% of the fragments were in the
low, medium, and high abundance categories, respectively. Thus,
most of the mRNAs whose level was increased in the resistant
cells were of low abundance, whereas the majority of the mRNAs
whose level was decreased were of medium or high abundance.
DISCUSSION
In the present study we combined a PCR-based subtraction
strategy with cDNA array hybridization to identify mRNAs
differentially expressed in a single isogenic pair of cDDP-
sensitive and -resistant cells. In this pair, whose resistant pheno-
type has been stable over many generations, the resistant pheno-
type was found to be accompanied by changes in the level of
numerous mRNAs, most of which have never been linked to
cDDP resistance before. Studies of differential gene expression
have often been performed with techniques such as RT-PCR and
Northern blotting, which both have the disadvantage of permitting
simultaneous analysis of only a very limited number of genes. The
present study demonstrated that the approach of enriching for
differentially expressed mRNAs using the SSH technique followed
by analysis of the recovered fragments on cDNA arrays was
reasonably efficient in identifying differentially expressed genes.
Twenty-six percent of the fragments from the UP library and 8%
from the DOWN library corresponded to mRNAs that differed in
abundance by > 5-fold on at least one of three repeat array
hybridizations. Although modest, these percentages are of the
same order of magnitude as a recent study by Yang et al (1999)
who found that 23% of the 332 clones were differentially
expressed in oestrogen receptor-positive compared to -negative
cells.
The reproducibility of the membrane arrays was reasonably
good. There was a substantial numerical variation in the hybridiza-
tion signals between the arrays, but among the fragments demon-
strating a > 5-fold increase in one of the hybridizations, 90%
showed a difference of at least 2-fold in at least one of the two
additional hybridizations. This reproducibility was considered
good enough for screening purposes.
The SSH technique includes a step directed at normalizing the
abundance of different cDNAs to facilitate the identification of
mRNAs that are differentially expressed but whose absolute levels
are too low to be detected by Northern blot analysis. The results of
the present study demonstrate that the SSH technique was efficient
in recovering such mRNAs. Half (50%) of the differentially
expressed transcripts were below the limit of detection when
1052 A Johnsson et al
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Figure 2 Distribution of the ratios of mRNA level in the cDDP-resistant UMSCC10b/15S to that in the -sensitive UMSCC10b cells for each cDNA clone in the
UP and DOWN library, respectively. Hybridizations were performed with unsubtracted PCR-amplified probes. Each bar represents the mean value of three
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hybridized with cDNA produced from the mRNA of the parental
UMSCC10b and radiolabelled without any PCR amplification.
The issue of whether microarrays are better or worse than 
Northern blot analyses for quantification of mRNA level remains
unresolved, but is in any case moot for many of the mRNAs iden-
tified in this study because of their low abundance.
The difference in level of expression was modest for most of the
identified mRNAs. However, for 20% of mRNAs in the UP library
the difference was > 10-fold. The finding that the majority of
mRNAs show little change, and a progressively smaller fraction
shows incrementally larger changes, is consistent with results
obtained in other systems where isogenic cells growing under
different conditions have been compared (Zhang et al, 1997; Zhou
et al, 1998).
Based on the number of duplicates recovered in the UP and
DOWN libraries, it was estimated that 138 mRNAs were up-
regulated in the cDDP-resistant cells (95% CI 50–410) and 46 were
down-regulated (95% CI 20–160). These estimates are of the same
order of magnitude as those made for the number of differentially
expressed mRNAs in other isogenic comparisons (Zhang et al,
1997; Zhou et al, 1998). When the SAGE technique was used to
examine the levels of 45 000 mRNAs in colon cancer cells vs
normal colon epithelium, 289 transcripts were found to be differen-
tially expressed, 181 down- and 108 up-regulated (Zhang et al,
1997). A comparison of normal and malignant pancreatic cells
using the same technique identified 183 transcripts whose expres-
sion were significantly elevated in the cancer cells (Zhou et al,
1998). The estimated fraction of transcripts exhibiting significant
differences in expression in the cDDP-sensitive vs-resistant
cells was between 0.25 and 1%, and this is close to the estimate
of 1.5% made for normal vs malignant colon and pancreatic epithe-
lial cells (Zhang et al, 1997; Zhou et al, 1998). Thus, it appears that
acquired cDDP-resistance was accompanied by changes in only a
small fraction of all transcripts expressed in the parental cells.
The goal of this study was to identify mRNAs that might be
useful in diagnosing the cDDP-resistant phenotype rather than
documenting that any of them were in fact causative of cDDP
resistance. It is unlikely that the mRNAs changes identified in this
study were simply due to clonal variation, since we compared
entire cDDP-sensitive and -resistant populations rather than indi-
vidual clones. Many of the changes observed may be secondary
effects of the primary causative genetic changes that produce the
resistant phenotype. Nevertheless, such changes can be useful
markers of the cDDP-resistant phenotype, and among the changes
identified, several stand out as particularly interesting candidates
for investigation using additional pairs of cDDP-sensitive and 
-resistant cell lines. Cytochrome oxidase I is a good example due
to its very high level of upregulation in resistant cells, and to the
fact that it was isolated four times in the UP library. Increased
cytochrome oxidase I activity has been demonstrated in cDDP-
resistant variants of the MCF-7, 2008 and SCC-25 cell lines (Ara
et al, 1994). Mitochondria play a central role in apoptosis (Green
and Reed, 1998), and other studies have shown changes in mito-
chondrial membrane potential when tumour cells become resistant
to cDDP (Andrews and Albright, 1992).
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